ARQT vs HUM · rev $235.3M vs P/E 39, rev $129.66B
Arcutis Biotherapeutics Inc (ARQT) versus Humana Inc (HUM) — a side-by-side from cached financials, not a winner call.
Arcutis Biotherapeutics Inc (ARQT) is a biotechnology company listed on US.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
Latest reported ARQT revenue for 2026-06-30 was $235.3M. Net income was $3.7M. ARQT currently screens at market cap $1.64B.
Latest reported HUM revenue for 2025-12-31 was $129.66B. Net income was $1.19B. Revenue was up 10.1% from 2024-12-31 to 2025-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
ARQT currently screens at market cap $1.64B. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Not investment advice. Open the ARQT and HUM stock pages for the full models.
Not investment advice.